Reuters logo
BRIEF-Pharma Mar says Aplidin gets orphan drug status to treat multiple myeloma in Switzerland
2017年5月4日 / 早上8点10分 / 7 个月前

BRIEF-Pharma Mar says Aplidin gets orphan drug status to treat multiple myeloma in Switzerland

May 4 (Reuters) - Pharma Mar SA:

* Aplidin receives orphan drug status for the treatment of multiple myeloma in Switzerland

* The company submitted the Marketing Authorisation Application in the European Union at the end of 2016 Source text: bit.ly/2p8zftX

Further company coverage: (Gdynia Newsroom)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below